Blueprint Medicines Corp Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2016 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Blueprint Medicines Corp quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2016 to Q2 2024.
  • Blueprint Medicines Corp Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 62.9M shares, a 3.86% increase year-over-year.
  • Blueprint Medicines Corp annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 60.6M shares, a 1.54% increase from 2022.
  • Blueprint Medicines Corp annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 59.6M shares, a 1.92% increase from 2021.
  • Blueprint Medicines Corp annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 58.5M shares, a 7.31% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 62.9M +2.34M +3.86% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 61.6M +1.45M +2.42% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 60.6M +916K +1.54% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 60.7M +930K +1.56% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-26
Q2 2023 60.5M +899K +1.51% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 60.1M +814K +1.37% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 59.6M +1.12M +1.92% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 59.8M +1.11M +1.89% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 59.6M +1.21M +2.07% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 59.3M +1.29M +2.22% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 58.5M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 58.6M +3.48M +6.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 58.4M +4.19M +7.73% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 58M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q3 2020 55.2M +6.25M +12.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 54.2M Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q3 2019 48.9M +5.01M +11.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q1 2019 44.1M +397K +0.91% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
Q4 2018 43.9M +6.07M +16.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-17
Q3 2018 43.9M +4.79M +12.2% Jul 1, 2018 Sep 30, 2018 10-Q 2018-10-30
Q2 2018 43.9M +5.08M +13.1% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-01
Q1 2018 43.7M +10.5M +31.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 37.8M +10.3M +37.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 39.1M +11.9M +43.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-30
Q2 2017 38.8M +11.6M +42.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 33.2M +6.1M +22.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 27.5M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 27.3M Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 27.2M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 27.1M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.